Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan perioperative cardiac surgery outcome study
NL-OMON36241Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bosentan in Cardiovascular Malformation (CVM) and mitral valve disease (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Exercise capacity. Started Oct 2011; status: active, not recruiting.
02
Drugs
bosentan
03
Conditions
Cardiovascular Malformation (CVM)mitral valve disease
Beyond the preview
Go deeper on NL-OMON36241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36241.